A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells()()

The therapeutic effect in non–small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients. In this study, the novel small molecule indolizino[6,7-b]i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neoplasia
Hauptverfasser: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Neoplasia Press 2016
Schlagworte:
Original article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840272/
https://ncbi.nlm.nih.gov/pubmed/27108383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.02.005
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge